Abinet Aklilu

Abinet Aklilu is a Nephrology Instructor at Yale School of Medicine, affiliated with the Department of Internal Medicine. He holds appointments in the Clinical and Translational Research Accelerator (CTRA) and Yale Medicine. His academic background includes an MD from the University of Maryland (2016), residency at Rutgers New Jersey Medical School (2019), and a clinical fellowship at Yale New Haven Hospital (2021), complemented by an MPH in Global Health from the Yale School of Public Health (2022).

His research focuses on acute and chronic kidney diseases, particularly in critical care settings. Key areas include optimizing AKI management through multidisciplinary teams (KAT-AKI trial), evaluating medication safety protocols, and understanding long-term kidney outcomes post-COVID-19. He emphasizes health equity in clinical research, advocating for race-neutral kidney function estimation methods.

Recent work includes a randomized controlled trial on automated medication alerts for AKI prevention and a survey on dialysis patient experiences during the pandemic. He collaborates with experts like F. Perry Wilson and Dennis Moledina, contributing to peer-reviewed journals such as BMJ Open, Nature Communications, and Kidney360.

Awarded the 2025 Dostanic Award for excellence in clinical research, Aklilu actively participates in institutional initiatives like the Yale Center for Health and Justice (SEICHE). His clinical interests span nephrology education, interventional nephrology, and improving care pathways for complex renal patients.